Scientific article
French

Paraprotéines et atteintes réenales

Other titleParaproteinemia and renal diseases
Published inRevue médicale suisse, vol. 6, no. 238, p. 460-466
Publication date2010
Abstract

Paraproteinaemia is frequent in the population above 50 years of age. It is commonly associated in patients with multiple myeloma with diverse renal involvements, such as cast nephropathy, light chain deposition disease, amyloidosis and Fanconi syndrome. A rapid diagnosis is necessary to implement a specific and aggressive treatment in order to prevent development of end-stage renal disease. Plasma exchanges or daily dialysis with high-cut off filter associated with chemotherapy may decrease the plasmatic concentration and production of monoclonal light chains. Bortezomib, thalidomide and lenalidomide are promising therapeutic agents, whose effects in patients with myeloma-associated renal diseases should be more thoroughly studied. Autologous hematopoietic cell transplantation remains the standard of care treatment for eligible patients.

Keywords
  • Biopsy
  • Humans
  • Kidney/pathology
  • Kidney Diseases/*complications/therapy
  • Paraproteinemias/*complications/diagnosis/therapy
  • Prognosis
Citation (ISO format)
GRANDJEAN, Anne Pascale, DETTWILER, Sarah, SAUDAN, Patrick. Paraprotéines et atteintes réenales. In: Revue médicale suisse, 2010, vol. 6, n° 238, p. 460–466.
Identifiers
Journal ISSN1660-9379
478views
0downloads

Technical informations

Creation22/05/2012 15:15:21
First validation22/05/2012 15:15:21
Update time14/03/2023 17:29:47
Status update14/03/2023 17:29:47
Last indexation29/10/2024 19:47:58
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack